Cargando…
Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
Prophylactic cranial irradiation (PCI) is recommended for patients with limited-stage small-cell lung cancer (LS-SCLC) who respond well to initial treatment. However, PCI is often omitted because of its potential neurotoxicity in the era of modern diagnostic imaging devices. In the present study, we...
Autores principales: | Ueki, Kazuhito, Matsuo, Yukinori, Kishi, Noriko, Yoneyama, Masahiro, Yoshida, Hironori, Sakamori, Yuichi, Ozasa, Hiroaki, Hirai, Toyohiro, Mizowaki, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303600/ https://www.ncbi.nlm.nih.gov/pubmed/35780299 http://dx.doi.org/10.1093/jrr/rrac035 |
Ejemplares similares
-
Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
por: Kishi, Noriko, et al.
Publicado: (2022) -
Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021) -
Correction to: Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
Publicado: (2022) -
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab
por: Funazo, Tomoko Yamamoto, et al.
Publicado: (2019) -
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
por: Nomizo, Takashi, et al.
Publicado: (2017)